1471-2334-14-164 1471-2334 Research article <p>Children of Senegal River Basin show the highest prevalence of <it>Blastocystis</it> sp. ever observed worldwide</p> El SafadiDimadima.elsafadi@hotmail.com GaayebLobnalobna.gaayeb@gmail.com MeloniDionigiadionigia.meloni@riken.jp CianAmandineamandine.cian@gmail.com PoirierPhilippeppoirier@chu-clermontferrand.fr WawrzyniakIvanivan.wawrzyniak@univ-bpclermont.fr DelbacFrédéricfrederic.delbac@univ-bpclermont.fr DabboussiFouadfdaboussi@hotmail.com DelhaesLaurencelaurence.delhaes@pasteur-lille.fr SeckModoumodou.seck@espoir-sante.org HamzeMonzermhamze@monzerhamze.com RiveauGillesgilles.riveau@gmail.com ViscogliosiEriceric.viscogliosi@pasteur-lille.fr

Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), Inserm U1019, CNRS UMR 8204, Université Lille Nord de France, 1 rue du Professeur Calmette, BP 245, 59019 Lille cedex, France

Centre AZM pour la Recherche en Biotechnologie et ses Applications, Laboratoire Microbiologie, Santé et Environnement, Université Libanaise, Tripoli, Lebanon

Biomedical Research Center Espoir pour la Santé (CRB-EPLS), Saint-Louis, Senegal

Microbe Division/Japan Collection of Microorganisms (JCM), RIKEN BioResource Center, Tsukuba, Japan

Laboratoire Microorganismes: Génome et Environnement, CNRS UMR 6023, Université Blaise Pascal de Clermont-Ferrand, Aubière, France

BMC Infectious Diseases
<p>Tropical and parasitological diseases</p>
1471-2334 2014 14 1 164 http://www.biomedcentral.com/1471-2334/14/164 10.1186/1471-2334-14-16424666632
2211201319320142532014 2014El Safadi et al.; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Blastocystis sp Intestinal parasite Molecular epidemiology Pathogenicity PCR Subtyping Transmission Zoonosis

Abstract

Background

Blastocystis sp. is currently the most common intestinal protist found in human feces and considered an emerging parasite with a worldwide distribution. Because of its potential impact in public health, we reinforced the picture of Blastocystis sp. prevalence and molecular subtype distribution in Africa by performing the first survey of this parasite in Senegal.

Methods

Stool samples from 93 symptomatic presenting with various gastrointestinal disorders or asymptomatic children living in three villages of the Senegal River Basin were tested for the presence of Blastocystis sp. by non-quantitative and quantitative PCR using primer pairs targeting the SSU rDNA gene. Positive samples were subtyped to investigate the frequency of Blastocystis sp. subtypes in our cohort and the distribution of subtypes in the symptomatic and asymptomatic groups of children.

Results

By the use of molecular tools, all 93 samples were found to be positive for Blastocystis sp. indicating a striking parasite prevalence of 100%. Mixed infections by two or three subtypes were identified in eight individuals. Among a total of 103 subtyped isolates, subtype 3 was most abundant (49.5%) followed by subtype 1 (28.2%), subtype 2 (20.4%) and subtype 4 (1.9%). Subtype 3 was dominant in the symptomatic group while subtypes 1 and 2 were detected with equal frequency in both symptomatic and asymptomatic groups. The distribution of subtypes was compared with those available in other African countries and worldwide. Comparison confirmed that subtype 4 is much less frequently detected or absent in Africa while it is commonly found in Europe. Potential sources of Blastocystis sp. infection including human-to-human, zoonotic, and waterborne transmissions were also discussed.

Conclusions

The prevalence of Blastocystis sp. in our Senegalese population was the highest prevalence ever recovered worldwide for this parasite by reaching 100%. All cases were caused by subtypes 1, 2, 3 and 4 with a predominance of subtype 3. More than half of the children infected by Blastocystis sp. presented various gastrointestinal disorders. Such high prevalence of blastocystosis in developing countries makes its control a real challenge for public health authorities.

Background

Blastocystis sp. is an anaerobic protist that inhabits the gastrointestinal tract of humans and many groups of animals 1 2 3 4 . This cosmopolitan enteric parasite with a worldwide distribution 5 is often identified as the most common unicellular eukaryote reported in human fecal samples 1 . Indeed, its prevalence may exceed 50% in developing countries 6 7 and reach 20% in industrialized countries 8 9 . These differences may be explained by poor sanitary conditions, close animal contact, and consumption of contaminated food or water 10 11 12 . Such prevalence also suggests large-scale human-to-human 13 , waterborne, and zoonotic transmissions for Blastocystis sp. 14 . Numerous studies have demonstrated the resistance of cysts of the parasite in feces and environmental sources 15 highlighting the fecal-oral route as the main mode of transmission of Blastocystis sp. Moreover, a higher risk of infection has been identified in food and animal handlers, providing conclusive evidence on the transmission of the parasite between humans and animals 16 17 .

At the morphological level, Blastocystis sp. isolates from humans and animals have been reported to be roughly indistinguishable 1 . However, extensive genetic diversity among Blastocystis sp. isolates has been reported based on the comparison of the small-subunit (SSU) rDNA gene sequence 18 leading to the classification of Blastocystis sp. isolates into subtypes (STs) 19 . To date, according to recent epidemiological surveys in human and animal populations, 17 STs have been identified 2 but it is highly likely that other STs remain yet to be uncovered. Among the 17 STs, nine of them have been detected in humans with a varying prevalence 5 . Indeed, only four of them are frequent (ST1, ST2, ST3 and ST4) and represent around 90% of the subtyped isolates. A majority of human infections with Blastocystis sp. is attributable to ST3 but the distribution of the four predominant STs may vary among the areas studied. Thereby, ST4 is almost as common as ST1 and ST3 in some European countries but seems rare or completely absent in Africa, Asia, and America 5 20 . The other STs that are common in animal hosts i.e. ST5 to ST9, are rarely found in humans and are most likely the result of zoonotic transmission.

As Blastocystis sp. can be found in both symptomatic and asymptomatic patients its clinical relevance remained uncertain 1 . However, a converging bundle of recent in vivo, in vitro and genomic data strongly suggests that this microorganism may be pathogen 21 22 23 24 and allows proposing a model for pathogenesis of this parasite 25 particularly involving virulence factors as cysteine proteases 26 27 . Therefore, Blastocystis sp. should be associated with a variety of non-specific gastrointestinal disorders including diarrhea, abdominal pain, nausea and vomiting 1 22 and also suspected to be linked to irritable bowel syndrome (IBS) 25 28 and chronic or acute urticarial lesions 29 30 . In addition, Blastocystis sp. has increasingly been implicated in diarrheal illness in immunocompromised individuals including HIV/AIDS and cancer patients and transplant recipients 31 32 .

It has long been suggested that the pathogenesis of Blastocystis sp. may be dependent upon ST but recent epidemiological data remain contradictory 8 29 33 34 35 36 . Nevertheless, the likely pathogenic power of Blastocystis sp. coupled to its high prevalence in the human population raise crucial questions about its current burden in public health. Consequently, information on the prevalence of the parasite and the distribution of STs are starting to emerge in still poorly studied geographic areas as Africa. To date the available data concern only few African countries of the North and West such as Egypt 21 37 38 , Libya, Nigeria, and Liberia 5 and one Eastern African country, Tanzania 39 . Therefore, the aim of the present study was to reinforce the picture of Blastocystis sp. prevalence and ST distribution in Africa by performing the first survey of this parasite in Senegal. In this epidemiological study, we described the prevalence of Blastocystis sp. infection and ST distribution in a cohort of Senegalese children living in 3 rural villages in close contact with animals and with poor or no access to clean water and sanitation. The distribution of Blastocystis sp. STs in both asymptomatic and symptomatic individuals was investigated together with potential risk factors for transmission of the parasite.

Methods

Cohort and collection of samples

This work has been carried out as part of the "SchistoVAN" project (clinicaltrials.gov ID NCT01553552), sponsored by the Biomedical Research Centre EPLS (Saint-Louis, Senegal) ( http://www.espoir-sante.org). The present study was approved by the National Ethics Committee of the Ministry of Health of Senegal (September 2011; protocol number SEN11/43, clinicaltrials.gov: NCT01553552). Oral and written informed consents were obtained from the parents or the legal guardians of the children in accordance with the Code of Ethics of the World Medical association (Declaration of Helsinki). Children enrolled in the present study formed a sub-cohort of the "AnoPalAnoVac" project (clinicaltrials.gov ID NCT01545115) and were recruited on the basis of their age (6 to 10 years of age in October 2011) through village nurses, healthcare workers in the community and school directors. Date of birth was ascertained from vaccination cards or school register. A standardized questionnaire was completed for each child (see Additional file 1). In particular, children were asked about each gastrointestinal symptom individually including abdominal pain, diarrhea, and vomiting. This cross-sectional study was conducted in October 2011, in 3 villages of the Podor district located in northern Senegal: Agniam Towguel (16°32′N-14°48′W; total population (TP): 989; several temporary ponds, traditional housing, irrigated crops), Fanaye Diery (16°32′N-15°13′W; TP: 6781; animal husbandry, irrigated crops, some urbanized habitat), and Niandane (16°35′N-14°59′W; TP: 5100; rice and banana farming, irrigated crops, some urbanized habitat, no access to running water). In this region, the climate is Sahelian, with annual rainfall between July and September. Mean temperature ranges between 20°C and 30°C during the cool season (November to February) and between 25°C and 38°C during the warm season (March to October). In this study, stool samples were collected from 93 symptomatic and asymptomatic children (Agniam = 17; Fanaye = 38; Niandane = 38) presenting or not gastrointestinal disorders. These boys (n = 46) and girls (n = 47) were aged 6 to 10 years (median age 8.4; quartiles: 6.6; 9.5) (Table  1). Children presented no symptoms of severe illness and/or fever and were subject to a questionnaire that was designed to collect clinical data especially regarding recent diarrhea, vomiting, and abdominal pain. For storage and transport at -20°C to Lille, stool samples were added in Stool Transport and Recovery (S.T.A.R.) buffer (Roche) in a ratio of 1:3 according to the manufacturer’s recommendations then homogenized by shaking.

<p>Additional file 1</p>

Standardized questionnaire completed for each child in the study.

Click here for file

<p>Table 1</p>

Patients

Sex/age

Symptoms

Blastocystis sp. ST by non-qPCR a

Nucleotide differences b

Blastocystis sp. ST by qPCR

Accession no.

aAccording to the standard terminology including 17 STs 2 ; (Sc) and (P): non qPCRs using the primer pair described by Scicluna et al. 40 and Poirier et al. 20 , respectively.

bDetermined in the common region of clones belonging to the same ST and sequenced for each sample.

DSS1

M/6.2

Abdominal pain

1

KF848509

DSS2

F/5.9

Abdominal pain, diarrhea

3 (Sc)

0

KF848510

DSS3

M/6.8

3 (Sc)

KF848511

DSS4

F/6.1

Abdominal pain, vomiting

1 (Sc)

KF848512

DSS5

M/8.3

3

KF848513

DSS6

M/7.3

Abdominal pain, diarrhea

1 (Sc)

KF848514

DSS7

F/5.9

3

KF848515

DSS8

M/6.8

Abdominal pain, vomiting

1 (Sc)

KF848516

DSS9

F/9.2

Abdominal pain

3

KF848517

DSS10

M/9.7

Vomiting

3 (Sc)

0

KF848518

DSS11

F/10

Diarrhea, vomiting

3 (Sc)

KF848519

DSS12

M/8.8

Abdominal pain, vomiting

3

KF848520

DSS13

F/8.6

Abdominal pain

1 (Sc)

KF848521

DSS14

M/7

2 (Sc)

0

KF848522

DSS15

F/7.7

2 (Sc)

KF848523

DSS16

M/6.9

3

KF848524

DSS17

F/7.7

3

KF848525

DSS18

F/6.1

3 (Sc)

0 to14

KF848526-7

DSS19

M/8.7

2

KF848528

DSS20

M/9.7

Abdominal pain

2 (Sc)

KF848529

DSS21

F/6

Abdominal pain

1 (Sc)

KF848530

DSS22

M/10.1

Abdominal pain

3 (Sc)

KF848531

DSS23

M/7.7

Mixed 2 and 3 (P)

0

KF848532-3

DSS24

F/6.4

1 (Sc)

KF848534

DSS25

F/9.6

Abdominal pain

Mixed 3 and 4 (Sc)

0 to 4

KF848535-7

DSS26

F/6.5

Abdominal pain

Mixed 1, 2 and 3(Sc)

KF848538-40

DSS27

M/7.2

3 (Sc)

KF848541

DSS28

M/8

3 (Sc)

KF848542

DSS29

F/7.3

2

KF848543

DSS30

M/5.8

Abdominal pain

1

KF848544

DSS31

F/8.6

Abdominal pain

2 (Sc)

KF848545

DSS32

M/6.6

3 (Sc)

KF848546

DSS33

M/7.7

Abdominal pain

Mixed 2 and 3 (Sc)

0

KF848547-8

DSS34

M/9.5

Vomiting

3 (Sc)

KF848549

DSS35

M/7.7

Abdominal pain

3 (Sc)

0

KF848550

DSS36

F/5.9

Abdominal pain

3 (Sc)

KF848551

DSS37

M/7.4

2 (Sc)

0

KF848552

DSS38

F/9.7

Abdominal pain, diarrhea, vomiting

1 (Sc)

0

KF848553

DSS39

F/9.8

Abdominal pain

3

KF848554

DSS40

F/9.9

Abdominal pain, diarrhea, vomiting

2 (Sc)

KF848555

DSS41

F/9.7

Vomiting

3 (Sc)

0

KF848556

DSS42

F/10.2

Abdominal pain, diarrhea

1 (Sc)

KF848557

DSS43

M/9.3

2 (Sc)

KF848558

DSS44

M/10

Abdominal pain

3 (Sc)

KF848559

DSS45

F/8.9

Abdominal pain

3 (Sc)

0 to 14

KF848560-1

DSS46

F/10.2

Abdominal pain

3

KF848562

DSS47

F/10

3 (Sc)

0

KF848563

DSS48

M/9.8

3 (Sc)

0

KF848564

DSS49

F/10

2 (Sc)

KF848565

DSS50

F/10.2

1

KF848566

DSS51

M/9.4

1 (Sc)

KF848567

DSS52

M/9

Abdominal pain

1 (Sc)

KF848568

DSS53

F/8.1

1 (Sc)

KF848569

DSS54

M/8.5

Mixed 1 and 2 (Sc)

0

KF848570-1

DSS55

M/9.1

Abdominal pain

3 (Sc)

KF848572

DSS56

F/8.6

1 (Sc)

KF848573

DSS57

F/9.7

Abdominal pain

2 (Sc)

KF848574

DSS58

M/9.3

Abdominal pain

2 (Sc)

KF848575

DSS59

M/8.9

Abdominal pain

3 (Sc)

KF848576

DSS60

F/8.8

3 (Sc)

KF848577

DSS61

M/9.9

1

KF848578

DSS62

F/9.5

Abdominal pain

1

KF848579

DSS63

M/8.5

Abdominal pain

1 (Sc)

KF848580

DSS64

M/6.2

Abdominal pain

3 (Sc)

KF848581

DSS65

M/9.8

1 (Sc)

KF848582

DSS66

F/9.9

Abdominal pain

2 (Sc)

KF848583

DSS67

F/6.1

Abdominal pain

Mixed 1 and 4 (Sc)

0

KF848584-5

DSS68

F/6.1

1 (Sc)

0

KF848586

DSS69

F/6.8

1

KF848587

DSS70

F/7.8

Abdominal pain

3 (Sc)

KF848588

DSS71

F/6.7

Abdominal pain

3

KF848589

DSS72

M/6

Abdominal pain, vomiting

3 (Sc)

KF848590

DSS73

F/7

Abdominal pain

3 (Sc)

0

KF848591

DSS74

M/8.5

3

KF848592

DSS75

M/5.9

Abdominal pain

3

KF848593

DSS76

M/8.1

Abdominal pain

1

KF848594

DSS77

M/6.6

Abdominal pain

3 (Sc)

2 to 12

KF848595-7

DSS78

M/6.9

Abdominal pain

2

KF848598

DSS79

M/8.4

3 (Sc)

0 to 11

KF848599-600

DSS80

M/6.1

3

KF848601

DSS81

F/5.9

Abdominal pain

Mixed 2 and 3 (Sc)

0

KF848602-3

DSS82

F/9.8

Abdominal pain

3 (Sc)

0

KF848604

DSS83

M/6.4

1

KF848605

DSS84

F/9.2

2 (Sc)

KF848606

DSS85

F/6.8

Abdominal pain, vomiting

3 (P)

3 to 5

KF848607-9

DSS86

F/6.6

Abdominal pain

Mixed 1, 2 and 3 (P)

KF848610-2

DSS87

M/9.9

Abdominal pain

3 (P)

0

KF848613

DSS88

M/9.5

1 (P)

0 to 1

KF848614-5

DSS89

F/9.1

Diarrhea

3 (P)

0

KF848616

DSS90

F/9.5

3 (P)

0 to 1

KF848617-8

DSS91

F/9.4

1 (P)

0 to 3

KF848619-20

DSS92

F/6.1

Abdominal pain, diarrhea

3 (P)

0 to 3

KF848621-2

DSS93

M/6

3 (P)

0 to 1

KF848623-4

Clinical data and Blastocystis sp. STs among symptomatic and asymptomatic patients in Senegal

DNA extraction and molecular subtyping of Blastocystis sp. isolates

Samples stored in S.T.A.R. buffer were stirred and then centrifuged for 1 min at 1,000 g. Total genomic DNA was extracted from 200 μl of the cleared stool supernatant using the QiaAMP DNA Stool Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. For each sample, 5 μl of extracted DNA was submitted to non-quantitative Polymerase Chain Reactions (non-qPCRs) as previously described using two independent pairs of Blastocystis sp.-specific primers designed by Scicluna et al. 40 and Poirier et al. 20 , both targeting the small subunit (SSU) rDNA coding region. The respective 600 bp- and 320 bp-amplified domains have been shown to contain sufficient information for accurate subtyping of Blastocystis sp. isolates 20 40 . Non-qPCR amplifications were carried out in 50 μl according to standard conditions for Platinum Taq High-Fidelity DNA polymerase (Invitrogen). For each DNA sample, the non-qPCR product with the highest intensity on agarose gel was purified and sequenced. Direct sequencing of few non-qPCR products generated mixed signals that could reflect infections by different STs or was of poor quality probably due to a too small amount of parasite DNA matrix. Because of the difficulty in interpreting the corresponding DNA sequencing chromatograms, same samples were re-analyzed by non-qPCRs and positive bands of the expected sizes were purified and cloned as previously described 41 . Three positive clones containing inserts were arbitrarily selected for each sample and sequenced on both strands. The DNA samples negative by non-qPCRs were subsequently amplified using the real time qPCR assay developed by Poirier et al. 20 . Due to the high sensitivity of this detection method, various controls were performed to prevent artifacts related to contamination through different sources: DNA extraction controls (isolation of DNAs without stool and from a Blastocystis sp.-negative stool) subsequently used in qPCR assays and negative (DNA matrix replaced by water) and positive (DNA obtained from a Blastocystis sp. ST4 culture) qPCR controls. The expected 320 bp-amplified variable region of the SSU rRNA gene was directly sequenced for subtyping. The SSU rRNA gene sequences obtained in this study have been deposited in GenBank under accession numbers KF848509 to KF848624. Obtained sequences were compared with all Blastocystis sp. SSU rRNA gene sequences available from the National Centre for Biotechnology Information (NCBI) using the BLAST program. STs were identified by determining the exact match or closest similarity against all known Blastocystis sp. STs according to the updated classification by Alfellani et al. 2 .

Results and discussion

Screening for Blastocystis sp. in a cohort of Senegalese children using molecular methods

In this study, fecal samples were collected from 93 children, 46 boys and 47 girls, aged 6 to 10 years and living in 3 villages situated in the north of Senegal. This cohort consisted of two groups: one symptomatic composed of 54 children presenting variously with abdominal pain, vomiting, and diarrhea and one asymptomatic including 39 other children (Table  1). All 93 samples were screened for Blastocystis sp. by non-qPCR and qPCR methods using specific primer pairs amplifying distinct domains of the SSU rDNA coding region 20 40 . Non-qPCR products were directly sequenced or subsequently cloned whether the resulting sequence chromatogram showed double or poor quality signals. In the latter case that involved 32 samples, three positive clones containing inserts were arbitrarily selected and sequenced. Overall, 71 samples were identified as positive for Blastocystis sp. by non-qPCR methods. The remaining 22 samples negative by non-qPCR nevertheless proved to be positive for the parasite by qPCR. Thereby, by means of these different molecular approaches, Blastocystis sp. was recognized in 100% of stool samples of this Senegalese population. To our knowledge this represents the highest prevalence ever recovered worldwide for this parasite.

In almost all molecular epidemiological studies conducted to date, only one nucleic acid-based diagnostics methodology was used to identify and subtype Blastocystis sp. isolates in stool samples. Briefly, PCR screening of fecal samples can be achieved using ST-specific sequence-tagged-site (STS) primers or genus-specific primers with subsequent sequencing for ST identification. Several regions in the SSU rDNA gene have been proposed by different authors for sequencing 24 but the "barcode" region designed by Scicluna et al. 40 has been extensively used as in the present study. Advantages and limitations of these two PCR approaches were recently largely discussed 24 42 and a comparative study using both techniques recommended barcoding as the relevant method for Blastocystis sp. diagnosis and subtyping 43 . However, as confirmed from our data, direct sequencing of non-qPCR products may be unsuccessful in the case of mixed infections with more than one Blastocystis sp. ST in the same sample. Therefore subtyping of isolates in mixed infections requires cloning of the non-qPCR product and sequencing of several clones as previously suggested 44 . In addition, about 24% of the samples have not been diagnosed as positive for Blastocystis sp. by non-qPCR methods in our study. Hence, at this stage of our screening, the prevalence of the parasite was 76%, which greatly underestimated its true prevalence as determined in a second step by qPCR (100%). Consequently, our study confirmed the impact of detection methods to ascertain the actual prevalence of Blastocystis sp. in human populations and the interest and higher sensitivity of qPCR assays in comparison to non-qPCR methods for epidemiological surveys.

Although the prevalence of Blastocystis sp. never reached 100% in any cohort studied so far, it was described as very high in some developing countries specially, in children. By using non-molecular standard methods, the prevalence of the parasite already exceeded 40% in communities in Venezuela 45 , Peru 46 , Colombia 7 , and in school children or orphanage in Indonesia 6 , Thailand 47 , and Lebanon (El Safadi unpubl.). Moreover, the prevalence of Blastocystis sp. was around 60% in immigrants in the city of Naples (southern Italy) who came for a large majority from northern and western African countries 48 . In Libya, the prevalence of the parasite has been previously reported close to 30% 49 . In Senegal, although the prevalence of Blastocystis sp. had never been determined before, intestinal parasites (protozoa and helminths) represent for a long time a major public health problem. Indeed, the global prevalence of intestinal parasites in children ranged from 32% to 84% depending on the study areas 50 51 52 53 . Such impact of intestinal parasites previously reported in the Senegalese population is clearly in accordance with the pattern found for Blastocystis sp. in the current study.

Distribution of Blastocystis sp. STs in the Senegalese population and comparison with other African countries

In all the children, the expected SSU rDNA domains targeted by non-qPCR and qPCR methods were amplified and successfully sequenced. Each of the new SSU rDNA gene sequences obtained in this study showed very high similarity (98% to 100%) to homologous sequences of the other Blastocystis sp. isolates reported so far. The comparison with representative sequences of all known Blastocystis sp. STs allowed the direct subtyping of the new isolates (Table  1). As stated above, for 32 of the 93 samples, cloning of the non-qPCR product was necessary for subtyping and 3 positive clones were arbitrarily selected and sequenced. For 14 of these 32 samples, the three sequenced clones were identical (Table  1). For 10 other samples presenting infection by a single ST, clones showed 1 to 14 nucleotide differences between them. As previously suggested 40 41 , these nucleotide differences may reflect either coinfection with two isolates of the same ST or sequence variations between SSU rDNA gene copies within the same isolate 23 . Interestingly, the higher number of nucleotide difference between the clones (11 to 14) was observed in children infected by ST3. Recently, by analyzing and comparing respectively SSU rDNA sequences or data from multilocus sequence typing, Meloni et al. 44 and Stensvold et al. 54 revealed substantial intra-ST diversity in ST3 and more limited intra-ST2 and intra-ST4 variations. In either case, we have considered in the following analysis of our data that two different clones of the same ST identified in the same patient derived from the same isolate of Blastocystis sp. For the last 8 samples, mixed infections with two (6 samples) or three STs (2 samples) were identified (Table  2). The majority of the subtyped samples included in the present study (85/93) represented single infections. With the addition of 8 mixed infections consisting of two or three different isolates, we analyzed a total of 103 isolates. As summarized in Table  3, ST3 was the most common Blastocystis sp. ST in our Senegalese population (49.5%) followed by ST1 (28.2%), ST2 (20.4%) and ST4 (1.9%). The distribution of STs was almost similar between the three villages with a majority of infections attributable to ST3. The only significant difference was that ST1 followed at position 2 in Niandiane and Agniam Towguel and at position 3 in Fanaye Diery.

<p>Table 2</p>

Villages

Blastocystis sp. STs

Total no.

ST1

ST2

ST3

ST1/ST2

ST1/ST4

ST2/ST3

ST3/ST4

ST1/ST2/ST3

Agniam Towguel

5

2

9

0

0

0

0

1

17

Niandane

13

5

17

1

1

1

0

0

38

Fanaye Diery

7

8

19

0

0

2

1

1

38

Total no.

25

15

45

1

1

3

1

2

93

Single and mixed ST infections with Blastocystis sp. identified in the Senegalese cohort

<p>Table 3</p>

Villages

Blastocystis sp. STs (%)

Total no.

ST1

ST2

ST3

ST4

Agniam Towguel

6

3

10

0

19

Niandane

15

7

18

1

41

Fanaye Diery

8

11

23

1

43

Total no. (%)

29 (28.1)

21 (20.3)

51(49.5)

2 (1.9)

103

Blastocystis sp. ST distribution among Senegalese villages

The distribution of Blastocystis sp. STs in Senegal is quite similar to that observed in a majority of countries all over the world with a predominance of ST3 followed by ST1 then ST2 or ST4 5 . If we focused on the studies previously conducted in Africa, the only available reports concerned the ST distribution in Egypt 21 37 38 , Libya, Nigeria, Liberia 2 , and Tanzania 39 , the latter survey only including 6 isolates (Figure  1). Globally, ST1, ST2, and ST3 represent around 82% of all 369 African isolates subtyped so far including those of the present study. ST3 is highly prevalent in African countries with an average of 46% of the 369 isolates. Consequently, because ST3 is rarely found in animals, a large-scale human-to-human transmission might likely explain the predominance of this ST in African countries as also in the rest of the world. Three studies conducted in different cities in Egypt and that in Liberia have identified ST3 as the predominant ST, as was true for our study population. However ST1 was detected with the highest frequency in Libya and Nigeria, and ST2 in Tanzania. Since ST1 and ST2 are frequently found in various animal groups including livestock 2 4 55 , it can be hypothesized that a not yet evaluated proportion of human infections by both STs are of zoonotic origin. Interestingly ST4 was not detected in the studies reported in Egypt, Libya and Tanzania and its prevalence is quite low in Senegal (1.9%). Although ST4 was relatively frequent in Liberia (12%) and Nigeria (14%), these data confirmed that ST4 is much less frequently detected or absent in Africa while it is commonly found in Europe 5 34 . However, the reasons for the heterogeneous geographical distribution of ST4 remain unknown and its reservoir hosts have to be clarified. Additional STs including ST6 and ST7 were commonly found only in two studies carried out in Egypt 21 38 . Indeed, these STs were not detected in Senegal, Liberia, Nigeria, and Tanzania as in a third survey in Egypt 37 and only one isolate belonging to ST7 was identified in Libya. Both STs are usually hosted by birds (avian STs) 56 and rarely found in mammals. This was confirmed in the present study. Given their apparent host specificity, it is highly likely that human infections by avian STs are of zoonotic origin.

<p>Figure 1</p>

Distribution of Blastocystis sp. STs across African countries

Distribution of Blastocystis sp. STs across African countries. In the case of Senegal, distribution of STs in mixed infections indicated by an asterisk in the histogram was detailed.

The prevalence of mixed ST infections was 8.6% (8/93 samples) in our Senegalese cohort. This percentage is probably underestimated but roughly similar to that calculated (6%) by taking into account subtyped isolates from all epidemiological studies published to date (191 of 3171 samples) and listed by Alfellani et al. 5 . Mixed ST infections were found in all three villages of our study but with different proportions. In Agniam Towguel, only one mixed infection by 3 STs was found (ST1/ST2/ST3) (5.9%) while 4 mixed infections by 2 or 3 STs (10.5%) (ST2/ST3, ST3/ST4 and ST1/ST2/ST3) were recorded in Fanaye Diery. Regarding Niandane, 3 mixed infections by 2 STs (7.9%) were identified (ST1/ST2, ST1/ST4, and ST2/ST3) (Table  2). Mixed infections mostly corresponded to ST1, ST2, and ST3 isolates and were more likely to occur considering the high prevalence of each of these STs in our cohort. Curiously, the only two ST4 isolates of our study were identified in the context of mixed infections and not as part of single infections.

Distribution of Blastocystis sp. STs in symptomatic and asymptomatic groups

According to recent epidemiological reports, links between ST and pathogenicity are still matter of debate 8 29 33 34 35 36 41 . To highlight a possible relationship between ST and major intestinal symptoms associated with Blastocystis sp. infection (diarrhea, vomiting, and abdominal pain), the ST distribution was evaluated in our cohort of 93 symptomatic or asymptomatic children. Interestingly, the majority of children infected by Blastocystis sp. (54/93 or 58%) presented various gastrointestinal disorders as previously observed in a pediatric unit in Turkey 57 . In the following analysis, symptomatic (6) and asymptomatic (2) children presenting mixed infections by two or three STs were removed. Thereby the remaining 48 isolates from symptomatic children and 37 isolates from asymptomatic children were considered (Table  4). The most dominant ST in both groups was ST3, and 63% of the ST3 isolates were found in symptomatic individuals. Predominance or high prevalence of ST3 in symptomatic groups of patients was also shown for instance in France 41 , Australia 8 , Turkey 57 58 , and Iran 35 . Regarding ST1 and ST2 isolates, both STs were detected with equal frequency in the symptomatic and asymptomatic groups of our cohort (Chi square test, p = 0.845). However, ST1 was over-represented in groups of symptomatic individuals in previous epidemiological studies in China 59 , Turkey 60 , Iran 35 , Egypt 21 , and Lebanon 36 . Moreover, ST1 was the most prevalent ST in some cohorts presenting with IBS 38 61 and was shown to be pathogenic in rat models of blastocystosis 21 . In contrast, ST2 was not usually overrepresented in groups of symptomatic patients from different countries and Dogruman-Al et al. 57 suggested that ST2 was a non-pathogenic ST. However, in our study, the proportion of ST2 isolates in symptomatic patients was far from negligible. Moreover, all ST2 isolates identified in French and Australian sampling were from symptomatic individuals 8 41 . To complete our observations, it can also be underlined that the only two ST4 isolates found in our study were associated with symptoms but in the context of mixed ST infections (associated to ST1 or ST3). Therefore, the pathogenic potential of ST4 could not be assessed from our epidemiological data. However, a high prevalence of ST4 was recently found in Danish patients presenting with acute diarrhea 33 and Spanish symptomatic individuals 62 . Globally, no association between ST and symptom status was statistically significant from our present data.

<p>Table 4</p>

Group

Blastocystis sp. STs (%)

Total no.

ST1

ST2

ST3

Mixed infections

Symptomatic

13 (24)

7 (13)

28 (52)

6 (11)

54

Asymptomatic

12 (31)

8 (20)

17 (44)

2 (5)

39

Total no (%)

25 (27)

15 (16)

45 (48)

8 (9)

93

Distribution of Blastocystis sp. STs among symptomatic and asymptomatic children groups

Potential risk factors for transmission of Blastocystis sp. within the Senegalese cohort

The fecal-oral route is the main mode of transmission of Blastocystis sp. like the other common gastrointestinal parasites 1 . To reach a prevalence of 100% as in the present study, it is reasonable to argue that infection of Senegalese children by the parasite occurred through multiple transmission sources. Although we did not had the opportunity to collect and analyze environmental (mainly water samples) and animal samples, it appears clear that individuals living in small communities in a rural area with modest socio-economic status (average income of 0.5 $ per person per day in these Senegalese villages), poor hygiene sanitation, close contact with domestic animals and livestock, and water supply directly from well and river as in our study greatly increase their risks of infection by Blastocystis sp. Indeed, recent studies have revealed a human-to-human transmission coupled with a high prevalence of the parasite in a close community of girls in Thailand 13 as well as in a rural village in Nepal 14 whose description and environment (animals reared in or next to villager dwellings and rivers as water sources of the community) are quite similar to those of Senegalese villages. In this context, zoonotic transmission of Blastocystis sp. would be another significant source of infection due to the wide range of animals potentially infected with the parasite and in close contact with humans 2 4 55 56 . However the impact of this mode of transmission through contact with contaminated animal fecal materials coupled with poor hand hygiene of villagers remains difficult to quantify therefore that it involves STs frequently found in humans (ST1 to ST4) as in the present study. Finally, there is a concern that water should be a main source of infection by Blastocystis sp. although large-scale waterborne outbreaks involving the parasite have not yet been documented. Ability of Blastocystis sp. cysts, the only transmissible stage of this parasite to survive for long periods of time in the environment together with their low size 1 15 represent some factors that favor waterborne transmission of the parasite. In 2006, Blastocystis sp. has also been added by the World Health Organization to the list of waterborne parasites 63 . Blastocystis sp. was previously reported in drinking water, rivers, tanks, and sewage samples 11 12 14 15 64 . Interestingly, in these latter studies, the same STs were identified in both the water samples and the stools of consumers providing evidence for water transmission. In the Senegalese villages of the present study, river and wells represent the main water sources for drinking and cooking purposes as well as for bathing of the population. Consequently, water sources of this community potentially contaminated with human and animal feces, may largely facilitate transmission of Blastocystis sp. and should be considered as serious potential threats to consumers. Further, the analysis of fecal samples from animals living in or near the Senegalese villages and of water samples would help to confirm their epidemiological importance as sources of infection and contamination for inhabitants.

Conclusions

To our knowledge, this is the first investigation of prevalence and ST distribution of Blastocystis sp. in Senegal that, moreover, greatly expands the few data available on molecular epidemiology of this parasite in Africa. In this country, the prevalence of Blastocystis sp. in a cohort of children living in a rural area reached a peak of 100% never achieved before. Such high prevalence may reflect different exposure of individuals to animal (zoonosis) and environmental (waterborne) sources of infection together with large-scale human-to-human transmission. This study also raises questions about the real pathogenicity of Blastocystis sp. since more than half of children infected by this parasite presented various gastrointestinal symptoms and highlights the socioeconomic impact of blastocystosis in developing countries with low environmental conditions and quality of life. Finally, this epidemiological survey provides necessary information to public health authorities for urgently setting prevention (water quality assessments and primary education of dwellers regarding the modes of transmission) and control programs that should help to reduce the burden of Blastocystis sp.

Abbreviations

ST: Subtype; IBS: Irritable bowel syndrome.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LG and MS collected stools and patient data and helped in drafting the manuscript. DES, DM, AC, PP and IW collected and analyzed PCR and sequence data and helped in drafting the manuscript. EV, GR, MH, LD, FDe and FDa conceived, designed and coordinated the study and drafted the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This work was supported by grants from the Programme Orientations Stratégiques from the University of Lille 2, the Centre National de la Recherche Scientifique, the Institut Pasteur of Lille and the Biomedical Research Center EPLS (Sn). DES and MO were both supported by PhD fellowships from the Conseil National de la Recherche Scientifique and the Azm & Saade Association from Lebanon, DM by a PhD fellowship from the Regione Autonoma della Sardegna and a post-doctoral grant from the Japanese Society for Promotion of Science (JSPS) and AC by a PhD fellowship from the Ministère Français de l’Education Nationale, de la Recherche et de la Technologie.

<p>New insights on classification, identification, and clinical relevance of <it>Blastocystis</it> spp</p>TanKSClin Microbiol Rev20082163966510.1128/CMR.00022-08257015618854485<p>Genetic diversity of <it>Blastocystis</it> in livestock and zoo animals</p>AlfellaniMATaner-MullaDJacobASImeedeCAYoshikawaHStensvoldCRClarkCGProtist201316449750910.1016/j.protis.2013.05.00323770574<p>Diversity and distribution of Blastocystis sp. subtypes in non-human primates</p>AlfellaniMAJacobASPereaNOKrecekRCTaner-MullaDVerweijJJLeveckeBTannichEClarkCGStensvoldCRParasitology201314096697110.1017/S003118201300025523561720<p>Subtype distribution of <it>Blastocystis</it> isolates from a variety of animals from South Wales, Australia</p>RobertsTStarkDHarknessJEllisJVet Parasitol2013196858910.1016/j.vetpar.2013.01.01123398989<p>Variable geographic distribution of <it>Blastocystis</it> subtypes and its potential implications</p>AlfellaniMAStensvoldCRVidal-LapiedraAOnuohaESFagbenro-BeyiokuAFClarkCGActa Trop2013126111810.1016/j.actatropica.2012.12.01123290980<p>Parasitological and nutritional situation of school children in the Sukaraja district, West Java, Indonesia</p>PegelowKGrossRPietrzikKLukitoWRichardsALFryauffDJSoutheast Asian J Trop Med Public Health199728173190<p><it>Blastocystis</it> subtypes detected in humans and animals from Colombia</p>RamirezJDSanchezLVBautistaDCCorredorAFFlorezACStensvoldCRInfect Genet Evol2013doi:10.1016/j.meegid.2013.07.020. [Epub ahead of print]<p>Subtype distribution of <it>Blastocystis</it> isolates identified in a Sydney population and pathogenic potential of <it>Blastocystis</it></p>RobertsTStarkDHarknessJEllisJEur J Clin Microbiol Infect Dis20133233534310.1007/s10096-012-1746-z22996007<p>Diagnosis and subtype analysis of <it>Blastocystis</it> sp. in 442 patients in a hospital setting in the Netherlands</p>BartAWentink-BonnemaEMSGilisHVerhaarNWassenaarCJAvan VugtMGoorhuisAvan GoolTBMC Infect Dis20131338910.1186/1471-2334-13-389376531623972160<p>Molecular epidemiology of human <it>Blastocystis</it> in a village in Yunnan province, China</p>LiLHZhouXNDuZWWangXZWangLBJiangJYYoshikawaHSteinmannPUtzingerJWuZChenJXChenSHZhangLParasitol Int20075628128610.1016/j.parint.2007.06.00117627869<p>Drinking water: a possible source of <it>Blastocystis</it> spp. subtype 1 infection in schoolchildren of a rural community in central Thailand</p>LeelayoovaSSiripattanapipongSThathaisongUNaaglorTTaamasriPPiyarajPMungthinMAm J Trop Med Hyg20087940140618784233<p>Evaluation of the transmission mode of <it>B. hominis</it> by using PCR method</p>ErogluFKoltasISParasitol Res201010784184510.1007/s00436-010-1937-420544220<p>Identification of <it>Blastocystis</it> subtype 1 variants in the home for girls, Bangkok, Thailand</p>ThathaisongUSiripattanapipongSMungthinMPipatsatitpongDTan-ariyaPNaaglorTLeelayoovaSAm J Trop Med Hyg20138835235810.4269/ajtmh.2012.12-0237358332923166199<p><it>Blastocystis</it> sp.: waterborne zoonotic organism, a possibility?</p>LeeLLChyeTTKarmacharyaBMGovindSKParasit Vectors2012513010.1186/1756-3305-5-130343405022741573<p>Viable <it>Blastocystis</it> cysts in Scottish and Malaysian sewage samples</p>SureshKSmithHTanTAppl Environ Microbiol2005715619562010.1128/AEM.71.9.5619-5620.2005121466116151162<p>Molecular characterization of <it>Blastocystis</it> isolates from children and rhesus monkeys in Kathmandu, Nepal</p>YoshikawaHWuZPandeyKPandeyBDSherchandJBYanagiTKanbaraHVet Parasitol200916029530010.1016/j.vetpar.2008.11.02919136214<p>Molecular characterization of <it>Blastocystis</it> isolates from zoo animals and their animal-keepers</p>ParkarUTraubRJVitaliSElliotALeveckeBRobertsonIGeurdenTSteeleJDrakeBThompsonRCVet Parasitol201016981710.1016/j.vetpar.2009.12.03220089360<p>Molecular phylogenies of <it>Blastocystis</it> isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis</p>NoëlCDufernezFGerbodDEdgcombVPDelgado-ViscogliosiPHoLCSinghMWintjensRSoginMLCapronMPierceRZennerLViscogliosiEJ Clin Microbiol20054334835510.1128/JCM.43.1.348-355.200554011515634993<p>Terminology for <it>Blastocystis</it> subtypes–a consensus</p>StensvoldCRSureshGKTanKSThompsonRCTraubRJViscogliosiEYoshikawaHClarkCGTrends Parasitol200723939610.1016/j.pt.2007.01.00417241816<p>Development and evaluation of a real-time PCR assay for detection and quantification of <it>Blastocystis</it> parasites in human stool samples: prospective study of patients with hematological malignancies</p>PoirierPWawrzyniakIAlbertAElAHDelbacFLivrelliVJ Clin Microbiol20114997598310.1128/JCM.01392-10306768621177897<p>Pathophysiological variability of different genotypes of human <it>Blastocystis hominis</it> egyptian isolates in experimentally infected rats</p>HusseinEMHusseinAMEidaMMAtwaMMParasitol Res200810285386010.1007/s00436-007-0833-z18193282<p>Current views on the clinical relevance of <it>Blastocystis</it> spp</p>TanKSWMirzaHTeoJDWWuBMacAryPACurr Infect Dis Rep201012283510.1007/s11908-009-0073-821308496<p>Genome sequence of the stramenopile <it>Blastocystis</it>, a human anaerobic parasite</p>DenoeudFRousselMNoëlBWawrzyniakIDa SilvaCDiogonMViscogliosiEBrochier-ArmametCCoulouxAPoulainJSeguransBAnthouardVTexierCBlotNPoirierPNgGCTanKSWAntiguenaveFJaillonOAuryJDelbacFWinckerPVivarèsCPEl AlaouiHGenome Biol201112R2910.1186/gb-2011-12-3-r29312967921439036<p>Recent developments in <it>Blastocystis</it> research</p>ClarkCGvan der GiezenMAlfellaniMAStensvoldCRAdv Parasitol20138213223548084<p>New insights into <it>Blastocystis</it> spp.: a potential link with irritable bowel syndrome</p>PoirierPWawrzyniakIVivaresCPDelbacFElAHPLoS Pathog20128e100254510.1371/journal.ppat.1002545330545022438803<p>Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by <it>Blastocystis</it> cysteine proteases</p>MirzaHWuZTeoJDWTanKSWCell Microbiol2012141474148410.1111/j.1462-5822.2012.01814.x22587300<p>Characterization of two cysteine proteases secreted by <it>Blastocystis</it> ST7, a human intestinal parasite</p>WawrzyniakITexierCPoirierPViscogliosiETanKSDelbacFEl AlaouiHParasitol Int20126143744210.1016/j.parint.2012.02.00722402106<p>Oh my aching gut: irritable bowel syndrome, <it>Blastocystis</it>, and asymptomatic infection</p>BooromKFSmithHNimriLViscogliosiESpanakosGParkarULiLHZhouXNOkUZLeelayoovaSJonesMSParasit Vectors200814010.1186/1756-3305-1-40262784018937874<p><it>Blastocystis</it> sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms</p>VogelbergCStensvoldCRMoneckeSDitzenAStopsackKHeinrich-GrafeUPohlmannCParasitol Int20105946947110.1016/j.parint.2010.03.00920363362<p><it>Blastocystis hominis</it> associated acute urticaria</p>VermaRDelfanianKAm J Med Sci2013346808110.1097/MAJ.0b013e318280147823360793<p>Genetic variability of <it>Blastocystis</it> sp. isolates obtained from cancer and HIV/AIDS patients</p>TanTCOngSCSureshKGParasitol Res20091051283128610.1007/s00436-009-1551-519603182<p>Endemic and opportunistic infections in Brazilian solid organ transplant recipients</p>BatistaMWPierrottiLCAbdalaEClementeWTGiraoESRosaDRTIanhezLEBonazziPRLimaASFernandesPFCBCPadua-NetoMVBacchellaTOliveiraAPPVianaCFGFerreiraMSShikanai-YasudaMATrop Med Int Health2011161134114210.1111/j.1365-3156.2011.02816.x21692958<p><it>Blastocystis</it> sp. subtype 4 is common in Danish <it>Blastocystis</it>-positive patients presenting with acute diarrhea</p>StensvoldCRChristiansenDBOlsenKEPNielsenHVAm J Trop Med Hyg20118488388510.4269/ajtmh.2011.11-0005311036121633023<p>Subtype analysis of <it>Blastocystis</it> isolates in Swedish patients</p>ForsellJGranlundMStensvoldCRClarkCGEvengardBEur J Clin Microbiol Infect Dis2012311689169610.1007/s10096-011-1416-622350386<p>Genetic variability of <it>Blastocystis</it> sp. isolated from symptomatic and asymptomatic individuals in Iran</p>MoosaviAHaghighiANazemalhosseini MojaradEZayeriFAlebouyehMKhazanHKazemiBZaliMRParasitol Res20121112311231510.1007/s00436-012-3085-522948205<p>Molecular epidemiology of <it>Blastocystis</it> in Lebanon and correlation between subtype 1 and gastrointestinal symptoms</p>El SafadiDMeloniDPoirierPOsmanMCianAGaayebLWawrzyniakIDelbacFEl AlaouiHDelhaesLDei-CasEMallatHDabboussiFHamzeMViscogliosiEAm J Trop Med Hyg2013881203120610.4269/ajtmh.12-077723458955<p>Subtype analysis of <it>Blastocystis</it> isolates from symptomatic patients in Egypt</p>SouppartLMoussaHCianASanciuGPoirierPEl AlaouiHDelbacFBooromKDelhaesLDei-CasEViscogliosiEParasitol Res201010650551110.1007/s00436-009-1693-519953268<p>The pathogenic role of different <it>Blastocystis hominis</it> genotypes isolated from patients with irritable bowel syndrome</p>FouadSABasyoniMMFahmyRAKobaisiMHArab J Gastroenterol20111219420010.1016/j.ajg.2011.11.00522305500<p>Diversity and host specificity of <it>Blastocystis</it> in syntopic primates on Rubondo Island, Tanzania</p>PetrasovaJUzlikovaMKostkaMPetrzelkovaKJHuffmanMAModryDInt J Parasitol2011411113112010.1016/j.ijpara.2011.06.01021854778<p>DNA barcoding of <it>Blastocystis</it></p>SciclunaSMTawariBClarkCGProtist2006157778510.1016/j.protis.2005.12.00116431158<p>Molecular epidemiology of human <it>Blastocystis</it> isolates in France</p>SouppartLSanciuGCianAWawrzyniakIDelbacFCapronMDei-CasEBooromKDelhaesLViscogliosiEParasitol Res200910541342110.1007/s00436-009-1398-919290540<p><it>Blastocystis</it>: genetic diversity and molecular methods for diagnosis and epidemiology</p>StensvoldCRTrop Parasitol20133263410.4103/2229-5070.113896374566723961438<p>Comparison of sequencing (barcode region) and sequence-tagged-site PCR for <it>Blastocystis</it> subtyping</p>StensvoldCRJ Clin Microbiol20135119019410.1128/JCM.02541-12353623423115257<p>Mixed human intra- and inter-subtype infections with the parasite <it>Blastocystis</it> sp</p>MeloniDPoirierPMantiniCNoëlCGantoisNWawrzyniakIDelbacFChabéMDelhaesLDei-CasEFioriPLEl AlaouiHViscogliosiEParasitol Int20126171972210.1016/j.parint.2012.05.01222659011<p>Profiles of enteropathogens in asymptomatic children from indigenous communities of Merida, Venezuela</p>VelascoJGonzalezFDiazTPena-GuillenJAraqueMJ Infect Dev Ctries20115276285<p>Diagnosis of soil-transmitted helminthiasis in an Amazonic community in Peru using multiple diagnostic techniques</p>MachicadoJDMarcosLATelloRCanalesMTerashimaAGotuzzoETrans R Soc Trop Med Hyg201210633333910.1016/j.trstmh.2012.03.00422515992<p>Intestinal parasitic infestations among children in an orphanage in Patum Thani province</p>SaksirisampantWNuchprayoonSWiwanitkitVYenthakamSAmpavasiriAJ Med Assoc Thai200386S263S27012929999<p>Intestinal parasites in immigrants in the city of Naples (southern Italy)</p>GualdieriLRinaldiLPetrulloLMorgoglioneMEMaurelliMPMusellaVPiemonteMCaravanoLCoppolaMGCringoliGActa Trop201111719620110.1016/j.actatropica.2010.12.00321195044<p>Prevalence and clinical features of <it>Blastocystis hominis</it> infection among patients in Sebha, Libya</p>AlfellaniMAKhanAHAl-GazaouiRMZaidMKAl-FerjaniMASultan Qaboos Univ Med J200773540308641621654943<p>Cryptosporidiosis among intestinal parasitosis in Senegalese pediatric hospital patients</p>FayeONdirODiengTGayeOBahIBDiengYFayeIDialloSDakar Med1993381291327758369<p>Intestinal parasitic diseases and tinea of the scalp in Dakar school population: influence of environmental factors on the infestation level</p>GayeONdirOKaneABelmachiRNdiayeMDioufMDiedhiouMDialloSDakar Med19943957617493523<p>Intestinal parasitic diseases and environment in Sahelo-Sudanese towns: the case of Pikine (Senegal)</p>SalemGvan de VeldenLLaloéFMaireBPontonATraissacPProstARev Epidemiol Sante Publique1994423223338085049<p>Prevalence of intestinal parasites at the King Baudouin health center of Guediawaye (Senegal)</p>NdirIGayeASyMGayeONdirODakar Med20024716817115776669<p>Levels of genetic diversity vary dramatically between <it>Blastocystis</it> subtypes</p>StensvoldCRAlfellaniMClarkCGInfect Genet Evol20121226327310.1016/j.meegid.2011.11.00222116021<p>Genetic diversity of caprine <it>Blastocystis</it> from Peninsular Malaysia</p>TianCTTanPCSharmaRSugnaseelanSSureshKGParasitol Res2013112858910.1007/s00436-012-3107-322961236<p>Subtype distribution of <it>Blastocystis</it> isolates from synanthropic and zoo animals and identification of a new subtype</p>StensvoldCRAlfellaniMANorskov-LauritsenSPripKVictoryELMaddoxCNielsenHVClarkCGInt J Parasitol20093947347910.1016/j.ijpara.2008.07.00618755193<p>A possible link between subtype 2 and asymptomatic infections of <it>Blastocystis hominis</it></p>Dogruman-AlFDagciHYoshikawaHKurtÖDemirelMParasitol Res200810368568910.1007/s00436-008-1031-318523804<p>Molecular epidemiology of <it>Blastocystis</it> infection in Turkey</p>ÖzyurtMKurtÖMolbakKNielsenHVHaznedarogluTStensvoldCRParasitol Int20085730030610.1016/j.parint.2008.01.00418337161<p>A rat model to study <it>Blastocystis</it> subtype 1 infections</p>LiJDengTLiXCaoGLiXYanYParasitol Res20131123537354110.1007/s00436-013-3536-723892480<p>Identification of <it>Blastocystis hominis</it> isolates from asymptomatic and symptomatic patients by PCR</p>ErogluFGeneAElgunKKoltasISParasitol Res20091051589159210.1007/s00436-009-1595-619685075<p>Irritable bowel syndrome: is it associated with genotypes of <it>Blastocystis hominis</it></p>YakoobJJafriWBegMAAbbasZNazSIslamMKhanRParasitol Res20101061033103810.1007/s00436-010-1761-x20177906<p>High prevalence of subtype 4 among isolates of <it>Blastocystis hominis</it> from symptomatic patients of a health district of Valencia (Spain)</p>Dominguez-MarquezMVGunaRMunozCGomez-MunozMTBorrasRParasitol Res200910594995510.1007/s00436-009-1485-y19471964<p>Microbial fact sheets</p>World Health OrganizationWorld Health Organization Guidelines for Drinking Water quality (WHOGDWQ)Malta: Gutenberg42011271273<p>Evidence of waterborne transmission of <it>Blastocystis hominis</it></p>LeelayoovaSRangsinRTaamasriPNaaglorTThathaisongUMungthinMAm J Trop Med Hyg20047065866215211009

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/14/164/prepub